Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

General Hospital Corp. and Shiseido disclose psoriastatin polypeptides

June 18, 1997

Tazorac approved in the U.S.

June 18, 1997

La Jolla Cancer Res. Found. discloses integrin-binding peptides

June 17, 1997

NYU grants Medco option to license adenosine A2 agonists

June 16, 1997

Cellegy discovers compounds that modulate topical inflammatory and allergic responses

June 16, 1997

Favorable preclinical results with REPEL-CV for cardiovascular surgery

June 13, 1997

Merck & Co. continues to develop 5alpha-reductase inhibitors

June 11, 1997

Inhibitors of 5alpha-reductase prepared by Merck & Co.

June 10, 1997

Preparation and use of 5alpha-reductase type 1 inhibitors described by Merck & Co.

June 6, 1997

Penederm receives SBIR grant for research on vitamin D derivative

June 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...